IRME · As filed with the SEC
IR-Med cash flow statement, by quarter
The statement as IR-Med presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) · USD thousands
| USD thousands | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 | Q3 2023† 3 months ended Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||||
| Net Income | (701)† | (773) | (278)† | (598)† | (366)† | (657) | (1,271)† | (1,179)† |
| Adjustments to reconcile loss for the period to net cash used in operating activities: | ||||||||
| Total stock-based compensation | 87† | 54 | (18)† | 197† | 100† | 206 | 424† | 383† |
| Depreciation Expense | 4† | 3 | 4† | 4† | 4† | 9 | 0† | 4† |
| Financial expenses (income), net | — | — | — | — | (6)† | 3 | 8† | 0† |
| Non-cash financial expenses (income) | 413† | 520 | — | — | (6)† | — | — | — |
| Decrease in accounts receivable | 3† | 46 | (24)† | (15)† | 18† | 27 | 34† | 16† |
| Change in Accounts Payable | (50)† | 40 | 57† | 10† | (122)† | 54 | 51† | (35)† |
| Net cash used in operating activities | (71)† | (110) | (261)† | (395)† | (372)† | (358) | (754)† | (811)† |
| Purchase of property and equipment | — | — | — | — | — | — | (1)† | — |
| Net cash used in investing activities | — | — | — | — | — | — | (1)† | — |
| Cash flows from financing activities | ||||||||
| Proceeds from Debt Issuance | 0† | 39 | — | — | — | — | — | — |
| Repayment of short-term loan | — | (39) | 0† | — | — | — | — | — |
| Proceeds from Debt Issuance | 0† | 31 | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | 0† | 40† | — | — | 0† | 0† |
| Net cash provided by financing activities | 88† | 31 | 0† | 35† | — | — | 0† | 0† |
| Effect of Exchange Rate on Cash | (5)† | 1 | — | — | 2† | (1) | (2)† | 0† |
| Net decrease in cash and cash equivalents | 12† | (78) | (263)† | (361)† | 345† | (359) | (757)† | (812)† |
| Cash and cash equivalents as at the beginning of the period | 51 | 129 | 392 | 753 | 408 | 767 | 1,524 | 2,336 |
| Cash and cash equivalents as at the end of the period | 63 | 51 | 129 | 392 | 753 | 408 | 767 | 1,524 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.